Home
overview

Considerable progress has been made in immunogenicity over recent years, with innovative developments seen in predicting and controlling immunogenicity. Complex challenges to industry remain however.

At SMi’s 4th annual Immunogenicity conference, industry, regulatory and academic experts will gather to spark debate and progress on the causes of immunogenicity, predicting and preventing its effects, and its associated issues. Immunogenicity 2017 will offer unparalleled networking opportunities, deep insight into industry issues, and spotlight sessions on innovations and emerging technologies for immunogenicity.

Immunogenicity 2017 will explore the need for harmonisation across risk assessments and data reporting, as well as guidance for clinical trial design. We will offer deep exploration of the regulations surrounding immunogenicity testing, from the UK, Europe, and USA, giving exclusive opportunity for discussion and debate with key regulatory experts. With focus on delivering true value for our delegates, Immunogenicity 2017 will highlight and solve key challenges for industry experts. Insight into aggregations, next generation biologics, novel assays, humanisation of bio-therapeutics, and improvements to accurate risk assessment will be complemented by high level case studies.

• Guidance on UK and EU regulations surrounding immunogenicity and best practice risk assessment
• Targeted focus on immunogenicity; identifying, addressing and removing challenges to industry
• Highlight best practise risk assessment and mitigation through high level case studies
• Explore novel and innovative approaches to reducing immunogenicity
• Spotlight on new technology; Humanising proteins and new biotherapeutic solutions
• Personalising treatments with next generation biologic drugs
 

Directors, Group Leaders, Department Heads, Senior Scientists of: 

  • Immunogenicity
  • Immunology
  • Regulatory Affairs
  • Biologic Drugs
  • Pre Clinical Risk Assessment
  • Drug Development
  • Clinical Development

Abzena; Accord Healthcare; Baliopharm AG; Baxalta; Bioarctic Neuroscience; Bristol Myers Squibb; Crucell Vaccine Institute; EpiVax, Inc.; F.Hoffmann-La Roche AG; Free University Of Brussels; GSK; ImmunXperts; ISA Pharmaceuticals; mAbxience; Medimmune LLC; National Institute for Biological Standards and Control; Netera AS; NEXTERA AS; NIBSC; Pfizer; Pfizer Pharmaceuticals; ProImmune Ltd.; Public Health England; Selecta Biosciences; SGS CEPHAC EUROPE SAS; Smithers Avanza; Teva; TIGENIX SAU; UCB; University Of Manchester;

Conference programme

8:30 Registration & Coffee

9:00 Chairman's Opening Remarks

Oreda Boussadia

Oreda Boussadia, European Head of Business Development and Strategy , EpiVax, Inc.
View Bio

9:10 The ABIRISK project: an integrated approach to assess predictive markers of immunogenicity

Sophie Tourdot

Sophie Tourdot, Scientific Project Manager, INSERM
View Bio

• ADA assays standardisation
• Predictive tools
• Biomarkers identification
• Integrative prediction

9:50 Reporting of clinically relevant immunogenicity data for low risk molecules

Weiping  Shao

Weiping Shao, Director of Bioanalytical Operations , Regeneron Pharmaceuticals Inc

• Immunogenicity assays have become more sensitive and drug tolerant in recent years resulting in the detection of low titer, transient ADA responses which previously were not detected
• Low risk, fully human MAbs often generate mostly low titer, transient ADA responses which have little to no clinical relevance
• Reporting incidence of total ADA in these cases is not that informative since it may not be clinically relevant and does not guide practice
• Identifying and reporting the most clinically relevant ADA responses which are more likely to impact efficacy or safety would be more informative to both patients and health care providers

10:30 Morning Coffee

11:00 Cut point setting in the presence of pre-existing anti-drug antibodies

Matthias Hofmann

Matthias Hofmann, Senior Investigator, Novartis Institutes for BioMedical Research
View Bio

• Conventional methods for cut point (CP) setting may fail in case a considerable number of sera used for method validation contain pre-existing anti-drug antibodies (ADA). This would result in an overestimation of the CP and thus underestimation in the number of ADA positive samples within the examined study population
• Separating ADA positive and negative samples already during method validation by modelling two (or more) overlaying populations and using only the ADA negative population for CP setting proved to be a viable method to tackle this challenge
• Details on and limitations of the method will be discussed, as well as several examples be presented

11:40 Perspectives on EU immunogenicity guidance and data reporting

Isabelle Cludts

Isabelle Cludts, Scientist, NIBSC

12:20 Networking Lunch

13:20 ADA-Dependent hypersensitivity reactions in preclinical toxicology studies

Rob Caldwell

Rob Caldwell, Principal Research Scientist, Regulatory Toxicology, AbbVie
View Bio

14:00 Personalizing biologic therapy: In silico methods for risk assessment

Annie De Groot

Annie De Groot, CEO and CSO, EpiVax, Inc.

14:40 Afternoon Tea

15:10 Preclinical and early development of tolerogenic nanoparticles to mitigate the formation of anti-drug antibodies

Petr  Ilyinskii

Petr Ilyinskii, Director of Biology, Selecta Biosciences Inc.

15:50 Immunogenicity from basic immunology towards pragmatic solutions

Louis Boon

Louis Boon, Chief Scientific Officer, Bioceros
View Bio

• Humanization and selection of lead humanized version
• Cell line and process development
• Functional ADA bioassays

16:30 Chairman’s Closing Remarks and Close of Day One

Oreda Boussadia

Oreda Boussadia, European Head of Business Development and Strategy , EpiVax, Inc.
View Bio

8:30 Registration & Coffee

9:00 Chairman's Opening Remarks

Oreda Boussadia

Oreda Boussadia, European Head of Business Development and Strategy , EpiVax, Inc.
View Bio

9:10 Immunogenicity prediction tools: how close are we to predicting outcomes in clinic?

Vibha Jawa

Vibha Jawa, Director of Biologics and Vaccines Development , MSD
View Bio

• Overview of available predictive tools for biologics
• Layering of tools to increase accuracy of the clinical outcome
• Implementing a strategy in discovery phase to select better candidates

9:50 The impact on immunogenicity risk assessment – impact on bioanalytical strategies in determining immunogenicity

John  Smeraglia

John Smeraglia , Senior Director, Bioanalytical Sciences , UCB
View Bio

• Assessing risk of immunogenicity at each stage of development
• Bioanalytical strategies in pre-clinical and clinical development
o Robust assay development/ characterization
o Pre-study validation and in study validation
• Challenges associated with multi-domain biologics

10:30 Morning Coffee

11:00 Immunogenicity assessment in biosimilar clinical trials with a monoclonal antibody

Ivo Sonderegger

Ivo Sonderegger , Project Manager , Boehringer Ingelheim
View Bio

11:40 Challenges of in vitro immunogenicity risk assessment: case study of Nanobodies

Chloe Ackaert

Chloe Ackaert, Postdoctoral Researcher, Cellular and Molecular Immunology, Free University Of Brussels

12:20 Networking Lunch

13:20 Pre-clinical tools to assess imunogenicity

Axel Ducret

Axel Ducret, Project Leader in Discovery Proteomics, Roche
View Bio

• Application of in vitro early development
• Case studies with clinical antibodies

14:00 Unwanted immunogenicity of immuno-oncology drugs

Sofie Pattijn

Sofie Pattijn, Chief Technology Officer, ImmunXperts

• Immune checkpoint-based immunotherapy has shown remarkable clinical benefits in a variety of cancer diseases but these new treatment modalities can also induce an array of immune-related adverse effects such as induction of auto-immunity and anti-drug-antibody based anaphylaxis
• Early tools like in silico and in vitro immunogenicity assessment tests should be applied during the development phase in order to avoid any risk of unwanted immunogenicity

14:40 Afternoon Tea

15:10 An integrated approach to managing immunogenicity risk and drug immune modulation

Jeremy Fry

Jeremy Fry, Director of Sales, ProImmune Ltd.
View Bio

• Learn how data from cell-based assays, physical MHC-peptide binding assays and mass spectrometry antigen presentation assays can be integrated to characterize immune responses against, or caused by, bio therapeutic drugs
• Mitigate the risk of first infusion reactions using whole-blood cytokine release assays.
• Improve decision-making in lead selection, lead characterisation and re-engineering options

15:50 Panel discussion: cancer (immunosuppressive) vs. autoimmunity (inflammatory

Louis Boon

Louis Boon, Chief Scientific Officer, Bioceros
View Bio

Sofie Pattijn

Sofie Pattijn, Chief Technology Officer, ImmunXperts

Annie De Groot

Annie De Groot, CEO/CSO, EpiVax, Inc.

16:30 Chairman’s Closing Remarks and Close of Day Two

Oreda Boussadia

Oreda Boussadia, European Head of Business Development and Strategy , EpiVax, Inc.
View Bio

+

FEATURED SPEAKERS

Annie De Groot

Annie De Groot

CEO and CSO, EpiVax, Inc.
Oreda Boussadia

Oreda Boussadia

European Head of Business Development and Strategy , EpiVax, Inc.
Sofie Pattijn

Sofie Pattijn

Chief Technology Officer, ImmunXperts
Sophie Tourdot

Sophie Tourdot

Scientific Project Manager, INSERM
Vibha Jawa

Vibha Jawa

Director of Biologics and Vaccines Development , MSD

Annie De Groot

CEO and CSO, EpiVax, Inc.
Annie De Groot

Annie De Groot

CEO/CSO, EpiVax, Inc.
Annie De Groot

Axel Ducret

Project Leader in Discovery Proteomics, Roche
Axel Ducret

Axel Ducret is a protein biochemist by training who has been using mass spectrometry for the characterization and quantification of proteins in complex mixtures. Throughout his career first at Merck Frosst in Montreal (Canada), then at F. Hoffmann-La Roche in Basel (Switzerland), he has applied increasingly more complex proteomics strategies for the discovery and validation of biomarkers in tissue, biological fluids, or other complex biological systems. Lately, he has been actively involved in the development and application of MAPPs, a mass spectrometry strategy to identify and quantitate MHC-II peptides, for assessing the immunogenic liabilities of biomolecules prior to entry in human.

Chloe Ackaert

Postdoctoral Researcher, Cellular and Molecular Immunology, Free University Of Brussels
Chloe Ackaert

Isabelle Cludts

Scientist, NIBSC
Isabelle Cludts

Ivo Sonderegger

Project Manager , Boehringer Ingelheim
Ivo Sonderegger

Ivo Sonderegger is a DMPK Project Manager at Boehringer Ingelheim Pharma in Ingelheim am Rhein (Germany). He received his Ph.D. in Immunology from the Swiss Federal Insitute of Technology (Zürich, Switzerland) in the field of cytokine immunology. He then joined Molecular Partners AG in (Zürich, Switzerland) where he was responsible for in-vivo and in-vitro pharmacology in the R&D Department. He was also served as non-clinical pharmacokineticist and was a key contributor in the immunogenicity risk-assessment of the DARPin platform. In his current position at Boehringer Ingelheim Pharma, he is responsible for the non-clinical and clinical immunogenicity evaluation for biosimilar compounds. He directs assay development and validation of PK, ADA, and neutralizing antibody assays and manages bioanalytical testing activities for clinical trials of biosimilar compounds. Furthermore Ivo is responsible for the non-clinical pharmacology assays regarding similarity assessment of biosimilar compounds.

Jeremy Fry

Director of Sales, ProImmune Ltd.
Jeremy Fry

Jeremy Fry gained his DPhil. from the University of Oxford developing gene therapy strategies to induce immunological tolerance in transplant recipients. Jeremy joined ProImmune to generate a new class of MHC multimer staining reagents. For the past 14 years as ProImmune's Director of Sales, he has led the sales team in a growing business, focusing on technologies that radically improve our understanding of immune responses.

John Smeraglia

Senior Director, Bioanalytical Sciences , UCB
John  Smeraglia

John is the Senior Director of Bioanalytical Sciences in Non-Clinical Development at UCB with laboratories in the UK and Belgium. He has responsibilities for bioanalytical sciences to enhance and revolutionize the way that the quantitative bioanalysis is performed from pre-clinical development to post marketing for NBE’s and NCE’s . He is also responsible for providing bioanalytical leadership for Pharmacokinetic and Immunogenicity testing to advance drug development. John has held bioanalytical leadership positions in the US and EU with innovator drug development companies and CROs. He obtained his first degree in Medical Technology in the US and his second degree in Biomedical Sciences in the UK where his thesis focus on diagnostic markers in the treatment and management of diabetic nephropathy. His has developed his experience in bioanalytical sciences for the last 25 years and is the author of more than 30 peer reviewed publications.

Louis Boon

Chief Scientific Officer, Bioceros
Louis Boon

Dr. Boon received his Ph.D. in Biochemistry at the University of Amsterdam. In 2003 he was one of the founders of Bioceros BV were he currently hold a position of CSO. In addition, he held position as CSO for MacroZyme BV, 4AZA Bioscience NV, FF Pharma and VP Preclinical for PanGenetics BV and Tanox. Dr. Boon is author of over 250 papers in international scientific journals in the field of medical biotechnology.

Bioceros has an impressive history with respect to development of novel therapeutics antibodies illustrated by their collaboration with J&J on one of their antibodies. In addition, Bioceros generates production cell lines for the industry and used its proprietary CHOBC® platform to generate a portfolio of cell lines producing biosimilar monoclonal antibodies. Since the acquisition of Bioceros by EPIRUS in 2015, he extended this expertise and developed a complete process toolbox to fit biosimilar CQAs. After the acquisition of Epirus NL by the Polpharma Biologics group in June 2016, he has continued to work on biosimilar development and innovative new molecular antibody entities, which now within the Polpharma Biologics group can be extended to GMP production and clinical testing.
 

Matthias Hofmann

Senior Investigator, Novartis Institutes for BioMedical Research
Matthias Hofmann

1992 – 1999: Diploma in Biochemistry (Studies in Würzburg, Germany, Tübingen, Germany & Austin, TX, USA)
1999 – 2002: PhD in Immunology (University of Tübingen)
2002 – 2005: PostDoc in Transplanation Research, Novartis Institutes for BioMedical Research, Basel, Switzerland
2005 – present: LabHead in Bioanalytics & Immunogenicity, Novartis Institutes for BioMedical Research, Basel, Switzerland

Oreda Boussadia

European Head of Business Development and Strategy , EpiVax, Inc.
Oreda Boussadia

Oréda is a Global and Corporate Executive Business Sales and Marketing Leader having experience in the biomedical research.
Experienced Science, Operations, Business, Sales and Marketing professional, driven to create value and achieve at the highest level within the Global CRO and Biotech markets. A visionary and a positive individual who embraces a culture of change. She continues to support innovative health industries with the need to strengthen to manage the business growth. Her main areas of expertise are: Global business awareness and market intelligence-define and implement business, sales, marketing and client service strategies-Develop of new products and services-Human resources management-Project management and organization-Define and implement operations strategy-Profitability and quality management. She is currently the European Head of Business Development and Strategy at Epivax - an immunology company that uses "immunoinformatics" computer modeling to develop new vaccines and to improve the immunogenicity profiles of new drugs. Before, Oréda was the Global Head of Sales, Marketing and Client services of Eurofins Pharma Discovery Services managing an annual revenue of $60M. She finalized the global organization within former Cerep, Panlabs, DDS-Millipore to build the Eurofins Pharma Discovery Services. Director of the Life Sciences Business Unit at Invest in Lyon she set up 22 foreign companies in Lyon region. Prior, Oréda was the Scientific Business Development Manager at Taconic Biosciences. During 3 years she built up a demand for Taconic offer and establish a solid brand in the smart solutions part of the French market. Taconic has seen its revenues increased by 32 % sales per year. As operations manager of the GEMS Genetically Engineered Model Services at Charles River France she achieved an annual increase of 30% EBITA and 16% of revenues . Before to join industries, she spent 10 years as a researcher in Max Planck Institute and in Gustave Roussy Institute, she has got 10 international research publications on cancer field http://www.ncbi.nlm.nih.gov/pubmed/.

Petr Ilyinskii

Director of Biology, Selecta Biosciences Inc.
Petr  Ilyinskii

Rob Caldwell

Principal Research Scientist, Regulatory Toxicology, AbbVie
Rob Caldwell

Rob is a toxicologist at AbbVie, where he has worked for the last 10 years. Rob’s main responsibility is to manage the preclinical toxicology strategy for drug development teams, supporting the overall safety assessment of new drugs. He works primarily on rheumatologic therapies but has also worked with antivirals and pain therapies. Prior to joining AbbVie, Rob worked at Covance Laboratories (a contract research laboratory) for 8 years where he lead the immunotoxicology program and conducted general toxicology studies for the pharmaceutical industry. Rob obtained his PhD in Immunology from Northwestern University in Chicago; where he studied mechanisms of Epstein-Barr virus latency and reactivation using transgenic mice.

Sofie Pattijn

Chief Technology Officer, ImmunXperts
Sofie Pattijn

Sophie Tourdot

Scientific Project Manager, INSERM
Sophie Tourdot

Sophie Tourdot received her Ph.D. in T cell vaccine immunology at the University of Paris. Following her postdoctoral trainings at Imperial College London, she worked at the Pasteur Institute on HIV vaccine design then progressed to Stallergenes and ITS, where she lead the Pre-clinical immunology teams. She currently works at Inserm as Scientific Project Manager for the IMI-funded ABIRISK project, a consortium of 38 partners from pharmaceutical companies and academic research centres across Europe, Israel and the United-States. The program focuses on the analysis of underlying biological mechanisms, clinical relevance and prediction of unwanted immunogenicity of biopharmaceuticals. Sophie Tourdot is also the Secretary General of the European Immunogenicity Platform.

Vibha Jawa

Director of Biologics and Vaccines Development , MSD
Vibha Jawa

Dr. Vibha Jawa is currently a Director, Biologics and Vaccine Bioanalytics at Merck where she is responsible for developing a strategy and provide oversight and management of scientific programs for discovery, development and optimization of biologics and vaccines. In this role, she is partnering with discovery and development groups to design better molecules. Her current research interests include evaluating immune response biomarkers for early drug development and efficacy, immunogenicity prediction using in silico, in vitro and in vivo technologies, modeling impact of immunogenicity on PK and PD, antigen processing and presentation and the role of T cells in immune response to drug products. Vibha has been actively involved in the American Association of Pharmaceutical Scientists (AAPS) as a Steering Committee member of the Therapeutic Protein Immunogenicity Focus Group (TPIFG) and currently is leading Immunogenicity Prediction Action Program Area (IPAPA). Dr Jawa obtained her Ph.D. in Biochemistry and Immunology with a thesis work studying the immune mechanisms behind autoimmune diseases followed by a postdoctoral fellowship at University of Pennsylvania on monitoring the immune response to viral vectors. She continued to work in the field of gene therapy company evaluating viral vectors for hemophilia therapy in the Bay area followed by City of Hope Cancer Centre Stem Cell and Gene Therapy group and at Amgen from 2003-2016.

Weiping Shao

Director of Bioanalytical Operations , Regeneron Pharmaceuticals Inc
Weiping  Shao

Sponsors and Exhibitors

Official Media Partner

Official Publication

Supporters

Workshops

Immunogenicity - from non-clinical detection to clinical impact
Workshop

Immunogenicity - from non-clinical detection to clinical impact

Holiday Inn Kensington Forum
14th June 2017
London, United Kingdom

VENUE

Holiday Inn Kensington Forum

97 Cromwell Road , London, United Kingdom

Holiday Inn Kensington Forum is perfectly situated in one of London’s most luxurious and beautiful areas within South Kensington. 

The hotel is just 2 minutes walk from Gloucester Road tube station for convenient travel to Hyde Park, London Eye, Tower Bridge plus more of London’s top attractions. There are also easy and direct links to some major transport hubs including Victoria, Kings Cross St Pancras, Paddington and Heathrow. 

This distinctive hotel in south London has so much to offer to make all guests really feel at home. The latest Holiday Inn relaunch is not just about the new look and feel for the hotel but to offer guests more benefits during their stay including a pillow menu for extra comfort during their sleep and a curved shower rail for more spacious feel. 

In addition to our 906 rooms, all business guests can take advantage of our meeting and conference facilities including High Speed Internet Access and unlimited Starbucks coffee at The Academy. Our hotel’s professional event planners are on board to help take the hard work and stress away from planning your next event. 

So whether you in London on business or pleasure, make the Holiday Inn London Kensington Forum your first choice of hotel and book your accommodation for our lowest internet rate guarantee. 

HOTEL BOOKING FORM

An Interview with Ivo Sonderegger, Project Manager, Boehringer Ingelheim

Download

An Interview with Kei Kishimoto, Chief Scientific Officer, Selecta Biosciences

Download

Sponsors and Exhibitors


SGS Cephac

Sponsors and Exhibitors
http://www.sgs.com/bioanalysis

SGS Cephac has a strong ImmunoAssay Department with strong experience in Immunogenicity Testing, including the use of the Immune Response Module of LIMS systems. SGS Cephac belongs to the SGS Life Science Network which is a leading Life Science bio/pharmaceutical, analytical and bioanalytical contract organization providing pharmaceutical development, biologics characterization, utilities qualification, biosafety, and quality control testing. Delivering solutions for pharmaceutical, biologics, and medical-device manufacturers, SGS offers GMP/GLP compliant contract laboratory services including analytical chemistry, microbiology, stability studies, bioanalysis, extractables and leachables, virology, and protein analysis. With 21 laboratories SGS leverages its wholly-owned global network, present in North America, Europe, and Asia, to deliver harmonized solutions.

Media Partners


Immunology of Infectious Disease News

Official Media Partner
http://www.immunologyofinfectiousdiseasenews.com/iidn?utm_source=Immunogen2015&utm_medium=logo&utm_campaign=iidnImmunogen2015

Immunology of Infectious Disease News is a free, weekly e-newsletter that keeps members of the infectious disease community informed by providing the latest news from all areas of the field, including science, research and business, to regulatory affairs. Subscribe now to stay current in the latest research news.


Human Immunology News

Official Media Partner
http://www.humanimmunologynews.com/hin?utm_source=Immunogen2015&utm_medium=logo&utm_campaign=hinImmunogen2015

Human Immunology News is a free, weekly e-newsletter that keeps members of the human immunology community informed by providing the latest news from all areas of the field, including science, research and business, to regulatory affairs. Subscribe now to stay current in the latest research news.


Immune Regulation News

Official Media Partner
http://www.immuneregulationnews.com/irn?utm_source=Immunogen2015&utm_medium=logo&utm_campaign=irnImmunogen2015

Immune Regulation News is a free, weekly e-newsletter that keeps members of the immune regulation community informed by providing the latest news from all areas of the field, including science, research and business, to regulatory affairs. Subscribe now to stay current in the latest research news.

Media Partners


International Journal of Cognitive Biometrics

Official Publication
http://www.inderscience.com/ijcb

Cognitive biometrics acquires information from users through collection of one or more biosignals. This relies on the presentation of one or more external or imagined stimuli. The subsequent response(s) are acquired and used for verification and authentication. IJCB addresses all aspects of cognitive biometrics, which aims to extract a unique signature from the user based on the cognitive, affective and conative state of the individual, either alone or more typically in various multi-modal combinations involving conventional and soft biometrics.


International Journal of Medical Engineering and Informatics

Official Publication
http://www.inderscience.com/ijmei

IJMEI promotes an understanding of the structural/functional aspects of disease mechanisms and the application of technology towards the treatment/management of such diseases. It seeks to promote interdisciplinary collaboration between those interested in the theoretical and clinical aspects of medicine and to foster the application of computers and mathematics to problems arising from medical sciences. IJMEI includes authoritative review papers, the reporting of original research, and evaluation reports of new/existing techniques and devices. Each issue also contains a comprehensive information service.


Int. J. of Immunological Studies

Official Publication
http://www.inderscience.com/ijis

IJIS publishes a broad range of papers on all aspects of immunology from scientists in academic and non-academic organisations as well as business and government worldwide. IJIS is the flagship journal of the Frontiers in Immunology Research Network.


International Journal of Behavioural and Healthcare Research

Official Publication
http://www.inderscience.com/ijbhr

IJBHR addresses a broad range of original experimental and theoretical papers that deal with behavioural and healthcare concerns. It welcomes high-quality papers from scientists in academic and non-academic organisations as well as business and government worldwide. IJBHR is sponsored by the Business and Economics Society International and the Frontiers in Immunology Research Network.


International Journal of Computational Biology and Drug Design

Official Publication
http://www.inderscience.com/ijcbdd

IJCBDD, an International Society of Intelligent Biological Medicine official journal, bridges the gap between two very important, complementary disciplines, computational biology and drug design. Through advances in high-throughput genome sequencing and digital imaging technologies, biocomputing, drug design and medical research have unfolded new, predictive sciences such as genomics, proteomics, lipidomics, metabolomics, cytomics and pharmaconomics. These promote new computational, statistical and biomedical approaches to drug design/development, besides unleashing the potential of significantly more accurate, effective personalised diagnosis, therapeutics and patient care.

Media Partners


EIN Presswire

Supporters
http://www.einpresswire.com/free

EIN Presswire has a distribution "foot-print" that includes millions of users of our EIN Newsdesk media monitoring services. We also maintain one of the world's leading media directories providing us with up-to-date contacts for media in every country and U.S. state. Further distribution is achieved via RSS, email, partner websites, and social media. We are both a destination (EIN Newsdesk) and a distributor (EIN Presswire) for news. In one place you can distribute your news to the targeted audiences you select and monitor news on that topic published by thousands of worldwide sources. For more information or to try us FREE, please visit www.einpresswire.com/free


Swiss Biotech Association

Supporters
http://www.swissbiotech.org/

The Swiss Biotech Association (SBA) is the national industry association for biotechnology, including pharmaceuticals, diagnostics, agriculture, food, cosmetics, environmental biotechnology, and specialty chemicals. Members are companies active in modern biotechnology, such as R&D, Production, Marketing and Sales, Finance, Services and Consulting. SBA provides a networking platform for Life Science clusters, academic and federal institutions the like. Founded in March 1998, the Association grows steadily.


ASD MEDIA

Supporters
http://www.asd-network.com

Professionals in the Aerospace & Defence market use the ASD Media internet platforms to:
  • Be informed on the latest market developments; www.asd-network.com
  • Find the latest business news; www.asd-network.com
  • Find the upcoming events; www.asd-network.com
  • Find companies and organizations; www.asdsource.com
  • Distribute news globally. www.asdwire.com
The ASD Media platforms are well known and used intensively, your company is able to benefit from these large numbers of users. Be informed with ASD-Network; Create exposure for your company with ASDSource, distribute your news with ASDWire or advertise with us, build your brand and increase traffic to your company’s website.

For more detailed information please contact with: ASD MEDIA
Stefan.koopman@asdmedia.nl


BioPharm Insight

Supporters
http://www.biopharminsight.com

BioPharm Insight is your definitive guide to the global life sciences community. Subscribers take action on forward-looking intelligence uncovered by an independent team of investigative journalists, and make strategic business decisions using the most comprehensive and powerful real-time database of market analytics and key contacts. Featuring an intuitive online interface and exclusive Active IntelT relational content technology, BioPharm Insight provides an unrivaled capability to segment and analyze the industry with detailed and searchable profiles.


Pharmacircle

Supporters
http://www.pharmacircle.com

PharmaCircle is an innovative knowledge management company serving the current and future global leaders in the Pharmaceutical and Biotechnology related industries. PharmaCircle is a one stop information and analysis source for pipeline, products, clinical trials, drug delivery technologies, deals and acquisitions, company financials, venture capital investments, product sales, pharmaceutical services, news, patents and more….


GBI

Supporters
http://www.gbihealth.com/

GBI is an information, applications, and services company focused on the healthcare industry. Leveraging data from across the healthcare value chain, GBI creates web and mobile applications that enable individuals and organizations to make better decisions and communicate more effectively.


Copybook - Pharmaceutical

Supporters
http://www.copybook.com/pharmaceutical

Copybook is a global business network with many pharmaceutical events, exhibitions and seminars. We encourage business-to-business transactions and work tirelessly to gain our customers new business contracts worldwide. You can add events, companies and associations for free. When you are a member, you can add your company to the events listed in order to encourage other visitors to arrange meetings and appointments at those events to facilitate new business contracts. Want to see how we can increase your business network and transactions? SIGN UP FOR FREE today! Copybook – Your Global Business Network


BioChem Adda

Supporters
https://www.biochemadda.com/

BioChem Adda is a Not-just-for-Profit organization which aims to bring out the most reliable and transparent information about everything related to jobs, careers, education, news, articles, and events from the field of BioSciences and Chemistry!


Absave

Supporters
http://www.absave.com

Absave.com is the leading savings website for Antibodies and Immunological Products. Search our extensive database of Antibodies, Kits, Proteins & Peptides, Reagents, etc. to find the best savings!


Biocompare

Supporters
http://www.biocompare.com

Biocompare.com is the leading resource for up-to-date product information, product reviews, and new technologies for life scientists. Biocompare combines an in-depth knowledge of life science products and new technologies with the power of the Internet to offer scientists the most dynamic, relevant, and innovative media-based marketplace for life science information.


Gate2Biotech

Supporters
http://www.gate2biotech.com

Gate2Biotech is a portal that unites biotechnological community in Central Europe. It covers all the news in the field of biotechnology. Thanks to the the portal the companies engaged in the field can easily search for research institutions and other partners to solve technical problems they are facing and here they can also present their services offer to potential partners from the Czech Republic and abroad. Gate2Biotech portal serves as a bridge connecting scientific and commercial sector. It incorporates offices and support organizations dedicated to promoting transfer of innovative technologies into a unified communication platform of Czech and international biotechnologies. As a mediator of information it draws attention to biotechnologies and support of their application and transfer into practice. It also functions as a tool for encouraging non-professionals (especially scientists and students) towards innovative business or applied research.


Farmavita

Supporters
http://www.farmavita.net/

Farmavita Net is professional community and network of pharmaceutical licensing and business development executives, innovators and researchers
Farmavita.Net is the pharmaceutical licensing, technology transfer and regulatory affairs network. We are managing the marketplace of offers and demand for pharmaceutical Dossiers, know-how and technologies. Members of Farmavita.Net network usually find a number of attractive solutions for business development, alliances, joint ventures, co-development and co-marketing of pharmaceutical products. Farmavita.Net is not just a pure Internet portal. We manage a number of regional associates. We are connecting the dynamic network of few hundreds members / pharmaceutical companies interested in license-in and license-out opportunities.


Labsave

Supporters
http://www.labsave.com

Labsave is the leading savings website for Laboratory Equipment and Lab Supplies. We work closely with the top suppliers in the world to bring you the best products at the most competitive prices. We are constantly striving to secure the biggest and most exclusive offers that you won’t find anywhere else! http://www.labsave.com/


pharmaphorum

Supporters
http://www.pharmaphorum.com

pharmaphorum drives innovation within the pharmaceutical industry, by bringing healthcare together through a suite of media services that help produce and disseminate thought leadership, combined with an online platform for communicating messages to a global audience.Visit www.pharmaphorum.com


Drug Discovery Today

Supporters
http://www.drugdiscoverytoday.com/

Drug Discovery Today is one of the most cited review journals in the field of drug discovery, with an impact factor of 6.422.
Drug Discovery Today will benefit your research by helping to keep you up-to-date with all of the fast-moving and emerging topics in drug discovery. Each issue is packed full of the latest research news, peer-reviewed articles and comment and opinion from leading research scientists.


AntibodyChain

Supporters
http://www.antibodychain.com

The complete and transparent marketplace for your research antibodies, kits, proteins and small molecules. The sophisticated search engine, with more than 800.000 products, transparency in suppliers, easy comparison, the one stop shop for your research antibodies in combination with interesting news and events plus a CMO exchange makes us a full service partner for you.


CanBiotech

Supporters
http://www.canbiotech.com

CanBiotech - A Portal and B2B Outsourcing Marketplace for the Biotech and Pharmaceutical Industry. The Marketplace features the Outsourcing Services Showcase; the Portal features our biopharmaceutical and venture capital directories and databases. Publications include the BioMedical Outsourcing Report and the Bio Outsourcing Asia© Publication.


Drug Target Review

Supporters
http://www.drugtargetreview.com

Drug Target Review’s quarterly magazine, website and annual events program provides high quality content with peer-written articles that are submitted exclusively by the world’s most respected scientists in their field. This attracts a committed base of readers, users and delegates made up of senior decision-makers from the life science and drug discovery industries at the top pharmaceutical companies, as well as academics and scientists from the top research institutes across the globe.


Pharmalicensing

Supporters
http://www.pharmalicensing.com

Pharmalicensing (www.pharmalicensing.com) is the premier biopharmaceutical Open Innovation resource designed for professionals involved with partnering, licensing and business development worldwide. Actively supporting all forms of partnering and in- and out-licensing activities, Pharmalicensing utilizes the unique Partnering Search service and its global network of industry experts to enable companies to identify and engage with appropriate partners around the world. Pharmalicensing, and its sister service Medical Device Licensing (www.medicaldevicelicensingcom) are actively utilized by over 200,000 industry professionals each month. Pharmalicensing is a division of IP Technology Exchange, Inc.


Pharmaceutical-Tech

Supporters
http://www.pharmaceutical-tech.com

In the realm of Pharmacy, where innovation is rapid, Pharmaceutical-Tech stands adept at conceptualizing unique ideas relevant to the B2B space. Pharmaceutical-Tech is essentially a B2B online business, technology media platform and global magazine that have under its wraps the largest global database of Pharmacy buyers and suppliers. Pharmaceutical-Tech.com covers in-depth trends that shape industry dynamics and metamorphose global economics. With services like search engine optimization, global magazine, social media marketing, product video showcase, e-mail marketing, e-newsletter sponsorship, banner advertising, event marketing and micro-website within our platform, www.pharmaceutical-tech.com has created a recognition that spans over a global audience, thereby revolutionizing how businesses transact.


Biosave

Supporters
http://www.Biosave.com

Biosave.com brings together the best Life Science promotions, product releases, featured products, publications, videos and events from 100’s of leading Life Science suppliers. Updated 24 hours a day, Biosave is constantly uploading special promotions and exciting product news that you won’t find anywhere else. Our goal is to provide our users with the most exclusive product information to help reach that all important purchasing decision.


International Pharmaceutical Industry

Supporters
http://www.ipimediaworld.com

IPI gives you an insight into all areas of Biopharm, Medical, Pharmaceutical and Healthcare. IPI provides a proven supportive means of communication to the Pharmaceutical, Bio Pharmaceutical, Nutraceutical and Medical Devices industry, incorporating the latest in research and technology innovations, regulatory guidelines, marketing and communication strategies.


Bentham Science

Supporters
http://www.benthamscience.com/

Bentham Science Publishers is a major STM journal publisher of 116 titles and 200 plus open access journals and print/online book series (Bentham eBooks). Bentham Science answers the information needs of the pharmaceutical and biomedical research community. Leading journals include Current Drug Metabolism (Impact Factor 5.113) and Current Medicinal Chemistry (Impact Factor 4.859): FREE online journals and information: www.benthamscience.com


Inderscience Publishers

Supporters
http://www.inderscience.com

Inderscience is a dynamic, leading, independent journal publisher. The company disseminates the latest research across the broad fields of science, engineering and technology; management, public and business administration; environment, ecological economics and sustainable development; computing, ICT and internet/web services, and related areas. Inderscience offers over 35 years' experience in publishing and has succeeded in building a substantial collection approaching 400 high-quality peer-reviewed international research journals in both online and print formats. We offer a variety of ways to keep up-to-date with the latest published leading-edge research while our online collection represents a fully-searchable digital archive of around 60,000 articles.


Select Science

Supporters
http://www.selectscience.net/

SelectScience is an independent, online information resource for the worldwide scientific community, and the home of trusted information for laboratory scientists. Discover impartial, expert opinion and trusted reviews about latest laboratory equipment and techniques; plus videos, application notes and science news from around the world. Become a member for free today.


CLocate

Supporters
http://www.clocate.com

Clocate.com is a leading international directory for worldwide conferences and exhibitions. Clocate.com is equipped with a unique and comprehensive search that helps you find easily any event in any category or location. Each event includes detailed information, like, description, dates, location, map, prices, link to the official event's website and more...


Mednous

Supporters
http://www.MedNous.com

MedNous is a print publication and website about medical innovation in Europe. It carries exclusive interviews with companies that are at the forefront of medical technology, as well as contributor articles from prominent practitioners. Our mission is to identify significant advances in medicine and to explain how this innovation is being commercialised. In doing so, we talk to venture capitalists about what products and platforms they are supporting. We report on how regulators cope with the accelerating pace of innovation. And we regularly cover the latest developments in the discovery and development of new medical concepts in the area of antibodies, vaccines, small molecules, regenerative medicine and nanomedicines. MedNous combines the English word for medicine with the Greek word for intellect. And those with nous are readers of our publication. Visit our website: www.mednous.com


Pharmaceutical Technology

Supporters
http://www.pharmaceutical-technology.com

Pharmaceutical-technology.com is the only website focusing specifically on issues relevant to pharmaceutical professionals working with technology, be it development, engineering, IT or production. Pharmaceutical-technology.com brings you the latest in industry projects and updates, along with the news, views and trends that leading professionals – from senior executives to manufacturing managers and heads of procurement – require to stay on top of their field.


Technology Networks

Supporters
http://www.technologynetworks.com

Founded in 2000, Technology Networks is established as the leading news provider for life science and drug discovery professionals. In addition, we provide unique content including webcasts, videos, application notes and posters from recent conferences. Our portfolio now includes around 30 focussed scientific communities, all of which are accessible free of charge within TechnologyNetworks.com


PMR

Supporters
http://www.pmrcorporate.com

PMR (www.pmrcorporate.com) is a British-American company providing market information, advice and services to international businesses interested in Central and Eastern European countries as well as other emerging markets. PMR's key areas of operation include business publications (through PMR Publications), consultancy (through PMR Consulting) and market research (through PMR Research ). Being present on the market since 1995, offering high international standards in projects and publications, as well as providing one of the most frequently visited and top-ranked websites, PMR is one of the largest companies of its type in the region.


Pharmiweb

Supporters
http://www.pharmiweb.com

Established in October 2003, PharmiWeb Solutions is an energetic, innovative provider of web-based solutions for the pharmaceutical sector, with customers such as AstraZeneca, Roche, Servier Laboratories, and Merck With solutions in three key areas: Online Publishing, e-Business and Mobile Computing, we deliver connectivity – between people and applications – unlocking islands of data and knowledge. We own some of the sector’s most innovative Online Publications: PharmiWeb.com, HospitalPharma.com and Detail-Direct.com. We are actively developing solutions for Mobile Computing platforms. For example, our PharmiTabTM e-pharmacy solution runs real-time patient data and prescribing transactions in a busy hospital environment, on a TabletPC, wireless client/server platform. e-Business solutions range from e-Detailing, to Online Market Research, all designed to increase reach, increase sales, and to reduce administration and costs.


Samedan

Supporters
http://www.samedanltd.com/magazine/13.

International Clinical Trials (ICT) is a quarterly magazine edited by Dr Graham Hughes, and written by specialists at the forefront of clinical research. ICT’s coverage of operational developments ranges from adaptive designs in early phase trials through to post marketing research. ICT’s targeted readership consists of key decision makers across the pharmaceutical and biotech industries, along with contract partners and consultants. The magazine is distributed to pharmaceutical professionals in Europe and North America, and is accessed globally online. Read the latest issues, explore the ICT archive and subscribe at www.samedanltd.com/magazine/13.


Drug Development Technology

Supporters
http://www.drugdevelopment-technology.com

Drugdevelopment-technology.com covers every aspect of the drug development and research process, from conception to pre-FDA approval. Our global network of journalists updates the site with the latest and most significant industry developments. This coverage allows us to provide everyone - from senior management through to research and QA staff – with in-depth reviews of the latest projects, advance notice of new product releases and analysis of the latest procedural and legislative developments.


Pharmavision

Supporters
http://www.pharmavision.co.uk

PharmaVision offers a consultancy service providing independent pharmaceutical thematic research to the healthcare industry, the investment community and competitive intelligence specialists. We perform due diligence research and provide expert commentary in healthcare. Our reports combine scientific analysis in drug delivery, R&D technologies and pharmaceutical products including patient modelling, product/technology forecasts and market trends evaluation.

SAVE TO


Outlook Calendar  OUTLOOK CALENDAR
Google Calendar  GOOGLE CALENDAR
ICal Calendar  ICAL CALENDAR
Yahoo! Calendar  YAHOO! CALENDAR

Holiday Inn Kensington Forum

97 Cromwell Road
London SW7 4DN
United Kingdom

Holiday Inn Kensington Forum

Holiday Inn Kensington Forum is perfectly situated in one of London’s most luxurious and beautiful areas within South Kensington. 

The hotel is just 2 minutes walk from Gloucester Road tube station for convenient travel to Hyde Park, London Eye, Tower Bridge plus more of London’s top attractions. There are also easy and direct links to some major transport hubs including Victoria, Kings Cross St Pancras, Paddington and Heathrow. 

This distinctive hotel in south London has so much to offer to make all guests really feel at home. The latest Holiday Inn relaunch is not just about the new look and feel for the hotel but to offer guests more benefits during their stay including a pillow menu for extra comfort during their sleep and a curved shower rail for more spacious feel. 

In addition to our 906 rooms, all business guests can take advantage of our meeting and conference facilities including High Speed Internet Access and unlimited Starbucks coffee at The Academy. Our hotel’s professional event planners are on board to help take the hard work and stress away from planning your next event. 

So whether you in London on business or pleasure, make the Holiday Inn London Kensington Forum your first choice of hotel and book your accommodation for our lowest internet rate guarantee. 

HOTEL BOOKING FORM

Title

SubTitle
speaker image

Content


Title


Description

Download


WHAT IS CPD?

CPD stands for Continuing Professional Development’. It is essentially a philosophy, which maintains that in order to be effective, learning should be organised and structured. The most common definition is:

‘A commitment to structured skills and knowledge enhancement for Personal or Professional competence’

CPD is a common requirement of individual membership with professional bodies and Institutes. Increasingly, employers also expect their staff to undertake regular CPD activities.

Undertaken over a period of time, CPD ensures that educational qualifications do not become obsolete, and allows for best practice and professional standards to be upheld.

CPD can be undertaken through a variety of learning activities including instructor led training courses, seminars and conferences, e:learning modules or structured reading.

CPD AND PROFESSIONAL INSTITUTES

There are approximately 470 institutes in the UK across all industry sectors, with a collective membership of circa 4 million professionals, and they all expect their members to undertake CPD.

For some institutes undertaking CPD is mandatory e.g. accountancy and law, and linked to a licence to practice, for others it’s obligatory. By ensuring that their members undertake CPD, the professional bodies seek to ensure that professional standards, legislative awareness and ethical practices are maintained.

CPD Schemes often run over the period of a year and the institutes generally provide online tools for their members to record and reflect on their CPD activities.

TYPICAL CPD SCHEMES AND RECORDING OF CPD (CPD points and hours)

Professional bodies and Institutes CPD schemes are either structured as ‘Input’ or ‘Output’ based.

‘Input’ based schemes list a precise number of CPD hours that individuals must achieve within a given time period. These schemes can also use different ‘currencies’ such as points, merits, units or credits, where an individual must accumulate the number required. These currencies are usually based on time i.e. 1 CPD point = 1 hour of learning.

‘Output’ based schemes are learner centred. They require individuals to set learning goals that align to professional competencies, or personal development objectives. These schemes also list different ways to achieve the learning goals e.g. training courses, seminars or e:learning, which enables an individual to complete their CPD through their preferred mode of learning.

The majority of Input and Output based schemes actively encourage individuals to seek appropriate CPD activities independently.

As a formal provider of CPD certified activities, SMI Group can provide an indication of the learning benefit gained and the typical completion. However, it is ultimately the responsibility of the delegate to evaluate their learning, and record it correctly in line with their professional body’s or employers requirements.

GLOBAL CPD

Increasingly, international and emerging markets are ‘professionalising’ their workforces and looking to the UK to benchmark educational standards. The undertaking of CPD is now increasingly expected of any individual employed within today’s global marketplace.

CPD Certificates

We can provide a certificate for all our accredited events. To request a CPD certificate for a conference , workshop, master classes you have attended please email events@smi-online.co.uk

Event Title

Headline

Text
Read More

I would like to speak at an event

I would like to attend an event

I would like to sponsor/exhibit at an event

SIGN UP OR LOGIN

Sign up
Forgotten Password?

Contact SMi GROUP LTD

UK Office
Opening Hours: 9.00 - 17.30 (local time)
SMi Group Ltd, 1 Westminster Bridge Road, London, SE1 7XW, United Kingdom
Tel: +44 (0) 20 7827 6000 Fax: +44 (0) 20 7827 6001
Website: http://www.smi-online.co.uk Email: events@smi-online.co.uk
Registered in England No: 3779287 VAT No: GB 976 2951 71




Forgotten Password

Please enter the email address you registered with. We will email you a new password.